Skip to content

Insider · CIK 0001805556

Adam Hansard

officer

Files at APLT (Applied Therapeutics, Inc.). First filing Dec 1, 2023, latest Mar 18, 2024.

In brief

Adam Hansard files SEC Form 4 as officer at APLT (Applied Therapeutics, Inc.). Since Dec 1, 2023, Adam Hansard has reported 0 open-market buys worth $0 and 2 open-market sells worth $265k, the latest filed on Mar 18, 2024.

A track record needs three past buys with six months of prices behind them; Adam Hansard has 0, so none is measured yet.

The newest scored trade: sold $263k of APLT on Mar 14, 2024, filed Mar 18, 2024, scored 43 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $265k sold

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
43Moderate
APLTsell 4
Applied Therapeutics, Inc.
$263k
48,871 shares
-6%-
30Weak
APLTsell 3
Applied Therapeutics, Inc.
$1,901
965 shares
-0%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
May 17, 2024 APLT
Applied Therapeutics, Inc.
115,777
0.10% of outstanding
$468kMay 17, 2024$1.1M
May 16, 2024 APLT
Applied Therapeutics, Inc.
179,425
0.16% of outstanding
$754kMay 16, 2024$296k

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 14, 2024APLT
Applied Therapeutics, Inc.
SOpen-market sale
Common Stock
-48,871$5.39$263k732,919Mar 18, 2024
Dec 21, 2023APLT
Applied Therapeutics, Inc.
AGrant or award
Common Stock
+400,000$0.00$0781,790Dec 22, 2023
Nov 30, 2023APLT
Applied Therapeutics, Inc.
SOpen-market sale
Common Stock
-965$1.97$1,901381,790Dec 1, 2023

Questions about Adam Hansard

Answered from the filings on this page, as of the latest one.

Is Adam Hansard buying or selling?

Not in the last 12 months. Adam Hansard's latest open-market trade on SEC Form 4 was sold $263k of APLT on Mar 14, 2024.

How did Adam Hansard's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adam Hansard has 0.

Where does Adam Hansard file Form 4?

Adam Hansard has filed Form 4 at APLT (Applied Therapeutics, Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Adam Hansard: insider trades and track record | InsiderTell